✦ LIBER ✦

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

✍ Scribed by Man-Fung Yuen; Erwin Sablon; Chee-Kin Hui; He-Jun Yuan; Hilde Decraemer; Ching-Lung Lai

Book ID: 111721613
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 88 KB
Volume: 34
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2001.27563

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

425 Lowest serum hepatitis B virus DNA l

425 Lowest serum hepatitis B virus DNA level is predicable factor for viral breakthrough during lamivudine therapy in chronic hepatitis B patients

✍ M. Cho; J. Heo; D.Y. Lyu; B.M. Cho; H.H. Kim; G.H. Kim; D.H. Kang; G.A. Song; U. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Factors associated with viral breakthrou

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

✍ Henry Lik-Yuen Chan; Albert Ka-Keung Chui; Wan-Yee Lau; Francis Ka-Leung Chan; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients receiv

Evolution of Hepatitis B Virus Polymeras

Evolution of Hepatitis B Virus Polymerase Gene Mutations in Hepatitis B e Antigen–Negative Patients Receiving Lamivudine Therapy

✍ Anna Suk-Fong Lok; Munira Hussain; Carmela Cursano; Marzia Margotti; Annagiulia 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

Evaluation of hepatitis B virus polymera

Evaluation of hepatitis B virus polymerase gene mutations in hepatitis-B-E-antigen-negative patients receiving lamivudine therapy

✍ H. Akkiz; Y. Ergun; M. Sandikci; S. Colakoglu; M. Serin; M. Oksuz; F.Y. Isiksal; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Hepatitis B virus variants in patients r

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

✍ Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Jia-Horng Kao; Ding-Shinn Chen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Clinical outcomes of chronic hepatitis B

Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy

✍ Ji H Kim; Sang K Yu; Yeon S Seo; Hyung J Yim; Jong E Yeon; Jong J Park; Jae S Ki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB